Nelfinavir Mesylate and Bortezomib in Treating Patients With Relapsed or Progressive Advanced Hematologic Cancer
Swiss Cancer Institute
Swiss Cancer Institute
Virginia Commonwealth University
Ohio State University Comprehensive Cancer Center
National Cancer Institute (NCI)